Featured Research

from universities, journals, and other organizations

Chemist gets U.S. patent for solution to antibiotic resistance problem

Date:
February 17, 2014
Source:
University of Copenhagen - Faculty of Science
Summary:
A chemist in Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria once again responsive to antibiotics.

Jorn Bolstad Christensen in his University of Copenhagen lab.
Credit: Image courtesy of University of Copenhagen - Faculty of Science

A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria once again responsive to antibiotics.

Jørn Bolstad Christensen and his colleagues hope that the substance will soon be able to tackle the tremendous problems associated with multidrug resistant tuberculosis (MDR-TB). But first, they need to find investors interested in getting the substance onto the market.

Before the development of penicillin, people dropped like flies in response to minor infections: in the lungs, in small cuts. Even pimples could grow to boils that killed. But one of the main killers prior to the discovery of antibiotics was tuberculosis.

The deadly infectious disease that typically affects the lungs has returned. It has developed a resistance to the majority of antibiotics that would otherwise kill the tuberculosis bacteria. Currently, the disease doesn’t pose an imminent threat to the industrialized world. However, resistant strains of the bacteria are nearing the region’s borders. This is one of the reasons why researchers around the world are busy trying to solve the problem of drug resistance.

Bacteria that have developed a resistance are still vulnerable to antibiotics, but they have developed an ability to shed bacteria killing substances before any damage is done to them. Colloquially, this is referred to as pooping the substance out, but the scientific formulation is that these bacteria activate an efflux pump. Jørn Bolstad Christensen has isolated a substance able to block the efflux pump so that an antibiotic remains in bacteria until the bacteria dies.

“You could say that we cure bacteria of their resistance, and slay them with antibiotics,” explains Associate Professor Jørn Bolstad Christensen.

Working with doctors Jette Kristiansen from the University of Southern Denmark and Oliver Hendricks from the King Christian X’s Hospital for Rheumatic Diseases in Gråsten, Denmark, Jørn Bolstad Christensen discovered that Thioridazin, an antipsychotic drug, was able to kill bacteria without any noticeably harmful effects upon humans. Still, the chemists had an idea that could make the substance even more benign.

Many chemical substances can be found in two very similar variations. Popularly put, these forms present a mirror image of one another. Chemists refer to these mirror images as chirals or isomers. It isn’t uncommon for two isomers of the same substance to have very different properties. In the case of Thioridazin, it has been shown that while both substances block the bacteria’s efflux pumps, one of them has considerably less of an effect upon the human brain. So Christiansen had to isolate the milder half of the substance.

“We now have a substance that is able to block the bacteria’s efflux pump. At very most, recipients of the medication may become slightly sluggish. This is also because very small doses are needed to affect the bacteria,” says Jørn Bolstad Christensen.

Because Thioridazin is an approved drug, the research team hopes that the new anti-resistance medication, JEK 47, will be approved without going through the entire process that new pharmaceuticals are typically subjected to. If this is the case, JEK 47 will most likely be a cheap medication that a pharmaceuticals manufacturer could release quickly. However if an investor does not show interest, Christensen is certain about his next step.

“I would rather donate this discovery to an NGO able to use this substance in poor countries that suffer from drug-resistance problems than watch it collect dust in the industrialised world. So, I hope that an investor comes along to develop this ground-breaking substance,” concludes Bolstad Christensen.


Story Source:

The above story is based on materials provided by University of Copenhagen - Faculty of Science. Note: Materials may be edited for content and length.


Cite This Page:

University of Copenhagen - Faculty of Science. "Chemist gets U.S. patent for solution to antibiotic resistance problem." ScienceDaily. ScienceDaily, 17 February 2014. <www.sciencedaily.com/releases/2014/02/140217085244.htm>.
University of Copenhagen - Faculty of Science. (2014, February 17). Chemist gets U.S. patent for solution to antibiotic resistance problem. ScienceDaily. Retrieved July 28, 2014 from www.sciencedaily.com/releases/2014/02/140217085244.htm
University of Copenhagen - Faculty of Science. "Chemist gets U.S. patent for solution to antibiotic resistance problem." ScienceDaily. www.sciencedaily.com/releases/2014/02/140217085244.htm (accessed July 28, 2014).

Share This




More Plants & Animals News

Monday, July 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Raw: Sea Turtle Hatchlings Emerge from Nest

Raw: Sea Turtle Hatchlings Emerge from Nest

AP (July 27, 2014) — A live-streaming webcam catches loggerhead sea turtle hatchlings emerging from a nest in the Florida Keys. (July 27) Video provided by AP
Powered by NewsLook.com
Trees Could Save More Than 850 Lives Each Year

Trees Could Save More Than 850 Lives Each Year

Newsy (July 27, 2014) — A national study conducted by the USDA Forest Service found that trees collectively save more than 850 lives on an annual basis. Video provided by Newsy
Powered by NewsLook.com
What's To Blame For Worst Ebola Outbreak In History?

What's To Blame For Worst Ebola Outbreak In History?

Newsy (July 27, 2014) — A U.S. doctor has tested positive for the deadly Ebola virus, as the worst-ever outbreak continues to grow. Video provided by Newsy
Powered by NewsLook.com
The New York Times Backs Pot Legalization

The New York Times Backs Pot Legalization

Newsy (July 27, 2014) — The New York Times has officially endorsed the legalization of marijuana, but why now, and to what end? Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins